UY31053A1 - Derivados heterociclicos, procesos para su produccion, medicamentos que comprende estos compuestos y su uso - Google Patents
Derivados heterociclicos, procesos para su produccion, medicamentos que comprende estos compuestos y su usoInfo
- Publication number
- UY31053A1 UY31053A1 UY31053A UY31053A UY31053A1 UY 31053 A1 UY31053 A1 UY 31053A1 UY 31053 A UY31053 A UY 31053A UY 31053 A UY31053 A UY 31053A UY 31053 A1 UY31053 A1 UY 31053A1
- Authority
- UY
- Uruguay
- Prior art keywords
- compounds
- processes
- production
- derivatives
- heterociclical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Derivados heterocíclicos, procesos para su produccion, medicamentos que comprende estos compuestos y su uso. La invencion se refiere a compuestos de formula I en la que los radicales R1, M, A, B, D, L y R son cada uno como se definio anteriormente, y a las sales fisiologicamente compatibles. Los compuestos resultan adecuados, por ejemplo, para el tratamiento del síndrome matabolico, la resistencia a la insulina, la obesidad y la diabetes.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07008646 | 2007-04-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY31053A1 true UY31053A1 (es) | 2008-11-28 |
Family
ID=38473076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY31053A UY31053A1 (es) | 2007-04-27 | 2008-04-25 | Derivados heterociclicos, procesos para su produccion, medicamentos que comprende estos compuestos y su uso |
Country Status (17)
Country | Link |
---|---|
US (2) | US8003677B2 (es) |
EP (1) | EP2152711B1 (es) |
JP (1) | JP2010524987A (es) |
KR (1) | KR20100015975A (es) |
CN (1) | CN101663306A (es) |
AR (1) | AR066290A1 (es) |
AT (1) | ATE489389T1 (es) |
AU (1) | AU2008248996A1 (es) |
BR (1) | BRPI0810858A2 (es) |
CA (1) | CA2685543A1 (es) |
CL (1) | CL2008001215A1 (es) |
DE (1) | DE502008001903D1 (es) |
IL (1) | IL201764A0 (es) |
MX (1) | MX2009011112A (es) |
TW (1) | TW200911809A (es) |
UY (1) | UY31053A1 (es) |
WO (1) | WO2008135141A1 (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010028761A1 (de) * | 2008-09-09 | 2010-03-18 | Sanofi-Aventis | 2-heteroaryl-pyrrolo[3, 4-c]pyrrol-derivate und ihre verwendung als scd inhibitoren |
US20120010186A1 (en) * | 2009-03-23 | 2012-01-12 | Merck Frosst Canada Ltd. | Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
ES2534516T3 (es) | 2010-01-07 | 2015-04-23 | E.I. Du Pont De Nemours And Company | Compuestos heterocíclicos fungicidas |
CN102260265B (zh) * | 2010-05-24 | 2015-09-02 | 上海阳帆医药科技有限公司 | 六氢吡咯[3,4-b]吡咯衍生物、其制备方法及其用途 |
BR112013004882A2 (pt) | 2010-08-31 | 2016-05-03 | Snu R&Db Foundation | utilização de reprogramação fetal de agonista ppar delta |
US8501768B2 (en) * | 2011-05-17 | 2013-08-06 | Hoffmann-La Roche Inc. | Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds |
JP6254087B2 (ja) | 2011-10-15 | 2017-12-27 | ジェネンテック, インコーポレイテッド | 癌を治療するためのscd1アンタゴニスト |
JP6258928B2 (ja) | 2012-06-13 | 2018-01-10 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 新規ジアザスピロシクロアルカンおよびアザスピロシクロアルカン |
AU2013322838B2 (en) | 2012-09-25 | 2018-02-01 | F. Hoffmann-La Roche Ag | New bicyclic derivatives |
AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
UA118201C2 (uk) | 2013-11-26 | 2018-12-10 | Ф. Хоффманн-Ля Рош Аг | НОВИЙ ОКТАГІДРОЦИКЛОБУТА[1,2-c;3,4-c']ДИПІРОЛ-2-ІЛ |
EA032357B1 (ru) | 2014-03-26 | 2019-05-31 | Ф. Хоффманн-Ля Рош Аг | Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa) |
EA037928B1 (ru) | 2014-03-26 | 2021-06-08 | Ф. Хоффманн-Ля Рош Аг | Бициклические соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa) |
WO2016046837A1 (en) | 2014-09-22 | 2016-03-31 | Cadila Healthcare Limited | An improved process for preparation of pyrrolo[3,4- c] pyrrole compounds and intermediates thereof |
MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
MX2020004504A (es) | 2015-09-04 | 2021-11-10 | Hoffmann La Roche | Derivados de fenoximetilo. |
PE20180552A1 (es) * | 2015-09-24 | 2018-04-02 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores duales de atx/ca |
MA42919A (fr) * | 2015-09-24 | 2018-08-01 | Hoffmann La Roche | Composés bicycliques utilisés en tant qu'inhibiteurs d'atx |
EP3353181B1 (en) | 2015-09-24 | 2021-08-11 | F. Hoffmann-La Roche AG | Bicyclic compounds as dual atx/ca inhibitors |
MA42918A (fr) | 2015-09-24 | 2018-08-01 | Hoffmann La Roche | Composés bicycliques utilisés en tant qu'inhibiteurs d'atx |
CN108299437B (zh) * | 2017-01-13 | 2022-07-08 | 广东东阳光药业有限公司 | 八氢吡咯并[3,4-c]吡咯衍生物及其用途 |
EP3596060B1 (en) | 2017-03-16 | 2023-09-20 | F. Hoffmann-La Roche AG | New bicyclic compounds as atx inhibitors |
RU2019132254A (ru) | 2017-03-16 | 2021-04-16 | Ф. Хоффманн-Ля Рош Аг | Гетероциклические соединения, пригодные в качестве дуальных ингибиторов atx/ca |
MD3448859T2 (ro) | 2017-03-20 | 2020-03-31 | Forma Therapeutics Inc | Compoziții de pirolopirol în calitate de activatori ai piruvatkinazei (PKR) |
BR112021005188A2 (pt) | 2018-09-19 | 2021-06-08 | Forma Therapeutics, Inc. | tratamento de anemia falciforme com um composto de ativação de piruvato cinase r |
JP7450610B2 (ja) | 2018-09-19 | 2024-03-15 | ノヴォ・ノルディスク・ヘルス・ケア・アーゲー | ピルビン酸キナーゼrの活性化 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005329423A1 (en) * | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
US7919496B2 (en) * | 2004-09-20 | 2011-04-05 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes |
-
2008
- 2008-04-16 BR BRPI0810858-7A2A patent/BRPI0810858A2/pt not_active Application Discontinuation
- 2008-04-16 AU AU2008248996A patent/AU2008248996A1/en not_active Abandoned
- 2008-04-16 DE DE502008001903T patent/DE502008001903D1/de active Active
- 2008-04-16 CA CA002685543A patent/CA2685543A1/en not_active Abandoned
- 2008-04-16 WO PCT/EP2008/003019 patent/WO2008135141A1/de active Application Filing
- 2008-04-16 JP JP2010504505A patent/JP2010524987A/ja not_active Withdrawn
- 2008-04-16 KR KR1020097022497A patent/KR20100015975A/ko not_active Application Discontinuation
- 2008-04-16 AT AT08735269T patent/ATE489389T1/de active
- 2008-04-16 CN CN200880012991A patent/CN101663306A/zh active Pending
- 2008-04-16 MX MX2009011112A patent/MX2009011112A/es not_active Application Discontinuation
- 2008-04-16 EP EP08735269A patent/EP2152711B1/de not_active Not-in-force
- 2008-04-24 AR ARP080101740A patent/AR066290A1/es unknown
- 2008-04-24 TW TW097114960A patent/TW200911809A/zh unknown
- 2008-04-25 CL CL200801215A patent/CL2008001215A1/es unknown
- 2008-04-25 UY UY31053A patent/UY31053A1/es not_active Application Discontinuation
-
2009
- 2009-10-26 IL IL201764A patent/IL201764A0/en unknown
- 2009-10-26 US US12/605,631 patent/US8003677B2/en not_active Expired - Fee Related
-
2011
- 2011-06-15 US US13/160,705 patent/US20110245263A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20110245263A1 (en) | 2011-10-06 |
WO2008135141A1 (de) | 2008-11-13 |
MX2009011112A (es) | 2009-10-28 |
TW200911809A (en) | 2009-03-16 |
AU2008248996A1 (en) | 2008-11-13 |
JP2010524987A (ja) | 2010-07-22 |
AR066290A1 (es) | 2009-08-12 |
IL201764A0 (en) | 2010-06-16 |
US20100144594A1 (en) | 2010-06-10 |
CL2008001215A1 (es) | 2008-09-22 |
KR20100015975A (ko) | 2010-02-12 |
CA2685543A1 (en) | 2008-11-13 |
DE502008001903D1 (de) | 2011-01-05 |
CN101663306A (zh) | 2010-03-03 |
US8003677B2 (en) | 2011-08-23 |
ATE489389T1 (de) | 2010-12-15 |
EP2152711A1 (de) | 2010-02-17 |
EP2152711B1 (de) | 2010-11-24 |
BRPI0810858A2 (pt) | 2014-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY31053A1 (es) | Derivados heterociclicos, procesos para su produccion, medicamentos que comprende estos compuestos y su uso | |
UY32094A (es) | Derivados heterocíclicos, procesos para su preparación, medicamentos que comprenden dichos compuestos y su uso. | |
CU20120099A7 (es) | Derivados de pirazina y su uso en el tratamiento de trastornos neurológicos | |
UY31351A1 (es) | (ciclopropilfenil)feniloxamidas, procedimiento para su preparación y su uso como medicamentos | |
UY31968A (es) | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos | |
CY1116424T1 (el) | Παραγωγο αδενινης ως αναστολεας ρι3κ | |
UY32799A (es) | Derivados de oxazina y su uso en el tratamiento de trastornos neurológicos | |
CR20140161A (es) | Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas | |
PE20180318A1 (es) | Procedimiento para preparar isoquinolinonas y formas solidas de isoquinolinonas | |
ECSP088666A (es) | Derivados de las benzamidas y heteroarenos | |
ECSP16078782A (es) | Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados | |
CU20140048A7 (es) | Novedosos derivados de purina útiles en el tratamiento del cáncer y trastornos neurodegenerativos | |
CO6781507A2 (es) | Novedosos derivados heterociclicos | |
CU20110088A7 (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales | |
ECSP12011830A (es) | Nuevos compuestos. | |
ECSP11011079A (es) | Nuevos compuestos de hidroxiareno. | |
UY31651A1 (es) | Nuevos derivados de fluoroglicósidos aromáticos, medicamentos que comprenden estos compuestos y uso de los mismos. | |
UY31645A1 (es) | Nuevas imidazolidinas fenil-sustituidas, procedimiento para su preparación, medicamentos que conprenden dichos compuestos y su uso. | |
UY28726A1 (es) | N-ciclohexilimidazolinonas sustituidas.procedimientos para su preparación y su uso como medicamentos. | |
UY31644A1 (es) | Imidazolina -2,4-dionas sustituidas, procesos para su preparación, medicamentos que comprenden estos compuestos y uso de los mismos. | |
DOP2014000114A (es) | Nuevos 2hindazoles como antagonistas del receptor ep2 | |
CR11057A (es) | Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos | |
UY31646A1 (es) | Uso de fenilimidazolidinas sustituidas para producir medicamentos para el tratamiento del síndrome metabólico | |
CO6460762A2 (es) | 5-alquinil-piridinas | |
DOP2007000121A (es) | Imidazolidina-2,4-dionas sustituidas con arilaminoarilalquilo, procedimiento para su preparación, medicamentos que comprenden estos compuestos y su uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20130408 |